Cortical Oxygenation and Serve Speed in Female Volleyball Players

November 12, 2026 updated by: İlimdar Taştanoğlu, Istinye University

Brain Cortical Oxygenation and Serve Speed During the Volleyball Serve: A Comparative Study Between Playing Positions

34 volunteer professional female volleyball players (aged 17-21), licensed in the Turkish Volleyball Federation (TVF) Women's Volleyball League 2 and 3, will be included in the study. No intervention will be applied. All participants will be assessed in a single session, in which cortical oxygenation of the prefrontal, premotor and motor cortex will be measured with a wireless fNIRS device and serve speed will be measured with a radar gun simultaneously during the volleyball serve.

Study Overview

Status

Not yet recruiting

Conditions

Detailed Description

34 professional female volleyball players licensed in the TVF Women's Volleyball League 2 and League 3, aged 17-21 years, with at least three years of regular training and competition experience, will be included using purposive sampling. Sample size was determined using G*Power 3.1 software (correlation: point biserial model, one-tailed) with 80% power, 0.05 type-1 error and an effect size of 0.40, giving a minimum of 34 participants. All participants will be assessed in a single session at the Istinye University Physiotherapy and Rehabilitation Application and Research Center (ISUFIZYOTEM). After a standardized 15-minute warm-up and placement of the fNIRS headset, each participant will perform five successful serves with 60 seconds of rest between serves, using the serve type they use most often in competition. Cortical oxygenation and serve speed will be recorded simultaneously for each serve. Measurements will be scheduled at least 24 hours after the last official match or high-intensity training session. Primary assessments include changes in oxyhemoglobin and deoxyhemoglobin in the prefrontal, premotor and motor cortex during the serve, measured with a wireless fNIRS device; serve speed, defined as the highest speed (km/h) of five successful serves and measured with a Bushnell Velocity Speed Gun radar; and demographic and anthropometric data, including age, height, body weight, body mass index, years of training, weekly training frequency, playing position and serve type.

Study Type

Observational

Enrollment (Estimated)

34

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

17 years to 21 years (Child, Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

Female volleyball players aged 17-21 years who hold an active license with Unsped Culture and Sports Club and compete in the Turkish Volleyball Federation (TVF) Women's 2nd and 3rd Leagues. Participants play as setter, outside hitter, opposite or middle blocker (liberos are excluded because they do not serve) and have at least three years of regular volleyball training and official competition experience. Players with musculoskeletal surgery in the last six months, current pain or acute injury affecting serving, or a neurological, vestibular, cognitive, cardiovascular, respiratory or metabolic condition limiting physical activity are excluded. Participants are recruited through the club and assessed in a single session at the Istinye University Physiotherapy and Rehabilitation Application and Research Center (ISUFIZYOTEM).

Description

Inclusion Criteria:

  • Holding an active license in the Turkish Volleyball Federation (TVF) Women's Volleyball League 2 or League 3 and participating in official competitions at the professional level.
  • Having at least three years of regular volleyball training and official competition experience.
  • Having the functional capacity to perform the serve independently, without pain, and in accordance with competition rules.

Exclusion Criteria:

  • Having undergone any musculoskeletal surgery within the last six months.
  • Presence of musculoskeletal pain, acute injury or functional loss that may affect serve performance prior to the assessment or testing procedures.
  • Having a diagnosed disease affecting neurological, vestibular or cognitive functions that may impair assessment results and sports performance.
  • Participation in moderate- to high-intensity physical activity being medically contraindicated due to cardiovascular, respiratory, metabolic or systemic disease.
  • Concurrently participating in an additional rehabilitation program, neuromodulation application or experimental performance-enhancement study during the research period.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: COHORT
  • Time Perspectives: CROSS_SECTIONAL

Cohorts and Interventions

Group / Cohort
Female Volleyball Players

In this study, the primary aim is to examine the correlation between serve speed and cortical oxygenation. The secondary aim is to examine differences in serve speed and cortical oxygenation between playing positions. Therefore, no separate groups are defined; all participants are analyzed as a single sample. No intervention is applied.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cortical Oxygenation Measured by Functional Near-Infrared Spectroscopy
Time Frame: Baseline

Changes in oxyhemoglobin and deoxyhemoglobin concentrations in the prefrontal, premotor and motor cortex during the volleyball serve will be measured with a wireless functional near-infrared spectroscopy (fNIRS) device. fNIRS is a non-invasive, portable neuroimaging method that indirectly assesses neural activation by measuring hemodynamic changes in the cortex through optical sensors placed on the head. The sensors will be positioned over the prefrontal, premotor and motor cortex, and cortical oxygenation changes will be recorded in real time. Each task will be repeated three times to ensure intra-subject reliability, and sensor signals will be checked after each repetition, with calibration performed if necessary.

Baseline
Serve speed
Time Frame: Baseline

Serve speed (km/h) will be measured with a Bushnell 1101911 Velocity Speed Gun radar. The device will be placed on a fixed tripod 5 meters from the net, parallel to the service line, and focused on the line where the ball passes at a height of approximately 1.5 meters, ensuring correct intersection of the radar beam with the ball. Each participant will perform five successful serves in accordance with competition rules, with a serve considered successful if the ball crosses the net and lands within the court. Sixty seconds of rest will be given between serves, and device calibration will be checked after each serve to minimize measurement errors. The highest recorded serve speed for each participant will be used as the performance indicator. All measurements will be performed under similar temperature and humidity conditions.

Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Director: Gül Deniz Yılmaz Yelvar, Istinye University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

November 20, 2026

Primary Completion (Estimated)

December 30, 2026

Study Completion (Estimated)

February 20, 2027

Study Registration Dates

First Submitted

November 12, 2026

First Submitted That Met QC Criteria

November 12, 2026

First Posted (Actual)

November 18, 2026

Study Record Updates

Last Update Posted (Actual)

November 18, 2026

Last Update Submitted That Met QC Criteria

November 12, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 2026/136

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.